"Refractory" eosinophilic airway inflammation in severe asthma: effect of parenteral corticosteroids (Q44950357)

7 December 2017

"Refractory" eosinophilic airway inflammation in severe asthma: effect of parenteral corticosteroids (English)

1 reference

7 December 2017

0 references

0 references

2

Aeilko H Zwinderman

1 reference

7 December 2017

Anneke ten Brinke

1

1 reference

7 December 2017

Peter J Sterk

series ordinal

3

1 reference

7 December 2017

Klaus F Rabe

series ordinal

4

1 reference

7 December 2017

Elisabeth H Bel

series ordinal

5

1 reference

7 December 2017

language of work or name

English

0 references

publication date

23 June 2004

1 reference

American Journal of Respiratory and Critical Care Medicine

7 December 2017

5

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

7 December 2017

170

1 reference

7 December 2017

601-605

1 reference

7 December 2017

6

1 reference

Heterogeneity in the pathology and treatment of asthma

7 December 2017

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-440OC

Non-eosinophilic asthma: importance and possible mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-440OC

Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-440OC

Heterogeneity of airway inflammation in persistent asthma : evidence of neutrophilic inflammation and increased sputum interleukin-8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-440OC

Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-440OC

Effect of high dose inhaled fluticasone propionate on airway inflammation in asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-440OC

Distinguishing severe asthma phenotypes: role of age at onset and eosinophilic inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-440OC

Relationship between the inflammatory infiltrate in bronchial biopsy specimens and clinical severity of asthma in patients treated with inhaled steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-440OC

Sputum induction in severe asthma by a standardized protocol: predictors of excessive bronchoconstriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-440OC

Bronchial inflammation in corticosteroid-sensitive and corticosteroid-resistant asthma at baseline and on oral corticosteroid treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-440OC

Airway structural alterations selectively associated with severe asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-440OC

Factors associated with persistent airflow limitation in severe asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-440OC

Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-440OC

Update on glucocorticoid action and resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-440OC

How do corticosteroids work in asthma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-440OC

Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-440OC

Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-440OC

Effect of HFA-flunisolide on peripheral lung inflammation in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-440OC

Kinetics of bone marrow eosinophilopoiesis and associated cytokines after allergen inhalation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-440OC

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-440OC

The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-440OC

Differences in Airway Inflammation in Patients with Fixed Airflow Obstruction Due to Asthma or Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-440OC

10.1164/RCCM.200404-440OC

21 January 2018

Identifiers

DOI

1 reference

7 December 2017

1 reference